SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K/A
Amendment No. 1
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2001.
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF
1934. FOR THE TRANSITION PERIOD _______ TO _______.
Commission File Number: 0-20727
Novoste Corporation
(Exact Name of Registrant as Specified in Its Charter)
Florida 59-2787476
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization Identification No.)
3890 Steve Reynolds Blvd., Norcross, GA 30093
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone, including area code: (770) 717-0904
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
(Title of Class)
Rights to Purchase Preferred Shares
(Title of Class)
Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
requirements for the past 90 days. Yes X No
--- ---
Indicate by check mark if disclosures of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K ( ).
As of March 1, 2002, there were 16,315,676 shares of Common Stock outstanding.
The aggregate market value of voting stock held by non-affiliates of the
Registrant was approximately $103,957,000 based upon the closing sales price of
the Common Stock on February 28, 2002 on the Nasdaq National Market. Shares of
Common Stock held by each officer, director, and holder of five percent or more
of the Common Stock outstanding as of March 1, 2002 have been excluded in that
such persons may be deemed to be affiliates. This determination of affiliate
status is not necessarily conclusive.
DOCUMENTS INCORPORATED BY REFERENCE
None.
Explanation of Amendment
This Item 5 of Part II is being amended to correct the range of closing sale
prices for the Common Stock for the year ended December 31, 2001. The high and
low closing prices for each quarter during 2001 were incorrectly stated in the
Form 10K filed by the Registrant on March 30, 2002.
PART II
Item 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS
The Company's Common Stock has been traded on the Nasdaq National Market (Nasdaq
symbol: NOVT) since May 1996. The number of record holders of the Company's
Common Stock at March 1, 2002 was 16,315,676 excluding beneficial owners of
shares registered in nominee or street name. The Company has not paid any
dividends since its inception, other than the distribution of the Shareholder
Rights described in Item 1: Issuance Of Preferred Stock May Adversely Affect
Rights of Common Shareholders or Discourage a Takeover, and does not intend to
pay any dividends in the foreseeable future. Pursuant to the terms of our
revolving line of credit we are restricted from paying dividends on our Common
Stock.
The range of high and low closing sale prices for the Common Stock is as
follows:
QUARTER ENDED HIGH LOW
-------------- ---- ---
Year Ended December 31, 2000
March 31, 2000 $48.7500 $17.0000
June 30, 2000 $61.0000 $36.2500
September 30, 2000 $60.8125 $39.1875
December 30, 2000 $43.4375 $22.5000
Year Ended December 31, 2001
March 31, 2001 $38.8750 $14.0000
June 30, 2001 $25.7500 $13.6250
September 30, 2001 $25.2500 $ 5.9300
December 31, 2001 $13.3100 $ 5.7300
On February 28, 2002 the last reported sale price for the Common Stock was
$6.70.
SIGNATURES
Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized, on April 24, 2002.
NOVOSTE CORPORATION
By: /S/ Thomas D. Weldon
--------------------
Thomas D. Weldon
Chairman and Chief Executive Officer
2